FDA approves Pharmion's Vidaza

The FDA granted marketing approval to PHRM for its Vidaza azacitidine to treat myelodysplastic syndromes (MDS). The company plans to

Read the full 203 word article

How to gain access

Continue reading with a
two-week free trial.